Skip to main content
Kimberly Smith, MD, Obstetrics & Gynecology, Sellersville, PA

KimberlyGailSmithMD

Obstetrics & Gynecology • Sellersville, PA

Stoneridge OB/GYN

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

  • Office

    670 Lawn Ave Ste 4
    Sellersville, PA 18960
    Phone+1 215-257-0414

Education & Training

  • Pennsylvania Hospital of the University of Pennsylvania Health System
    Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 2007 - 2011
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2007 - 2024
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

Press Mentions

  • ViiV Healthcare Announces Phase III Study Meets Primary Endpoint, Demonstrating the Ability to Control HIV-1 with a 2-Drug Regimen of Dolutegravir plus Lamivudine in Virally Suppressed Patients Switching from a TAF-Containing, 3-Drug Regimen
    ViiV Healthcare Announces Phase III Study Meets Primary Endpoint, Demonstrating the Ability to Control HIV-1 with a 2-Drug Regimen of Dolutegravir plus Lamivudine in Virally Suppressed Patients Switching from a TAF-Containing, 3-Drug RegimenJuly 10th, 2019
  • Dolutegravir-Based Two-Drug Regimen Just as Good for HIV Treatment as Three-Drug Therapy, Study Says
    Dolutegravir-Based Two-Drug Regimen Just as Good for HIV Treatment as Three-Drug Therapy, Study SaysAugust 6th, 2018
  • Health Hero: Here’s What This Doctor Wants Black Women to Know About HIV Right Now!
    Health Hero: Here’s What This Doctor Wants Black Women to Know About HIV Right Now!March 13th, 2018

Dr. Kimberly Smith, Dr. Kimberly Smith, MD, Dr. K Smith, Dr. Kimberly Gail Smith